Segmentation, Major Trends, and Competitive Overview of the Single-Photon Emission Computed Tomography (SPECT) Market

The single-photon emission computed tomography (SPECT) market is on track for significant expansion over the coming years, driven by technological progress and increasing demand in healthcare diagnostics. This evolving field is attracting attention for its role in enhancing molecular imaging and improving early disease detection, positioning it as a key segment in the medical imaging industry.

Projected Growth and Market Size of the Single-Photon Emission Computed Tomography (SPECT) Market
The global SPECT market is anticipated to reach a valuation of $3.92 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.5%. This upward trend is fueled by the rising need for advanced molecular imaging techniques, broader adoption of precision diagnostic tools, and the expansion of outpatient diagnostic facilities. Furthermore, the integration of artificial intelligence (AI) within medical imaging workflows and an increased emphasis on early identification of diseases are contributing to the market's steady gains. Key developments expected to shape the market include wider use of hybrid SPECT imaging systems, AI-supported image reconstruction, greater demand for cardiac and oncology imaging applications, growth in multi-head gamma camera systems, and a strengthened focus on enhancing diagnostic accuracy.

Download a free sample of the single-photon emission computed tomography (spect) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Key Factors Contributing to the Expansion of the SPECT Market
A growing emphasis on precision diagnostics is one of the primary factors driving the SPECT market forward. Healthcare providers are increasingly incorporating molecular imaging technologies to obtain more detailed insights into complex diseases, which supports tailored treatment approaches. This trend is especially prominent in oncology and cardiology, where early and accurate detection is critical for patient outcomes.

Additionally, the rise of outpatient diagnostic centers complements this growth, as these facilities provide greater accessibility to advanced imaging services without the need for hospital admission. This shift is encouraging broader usage of SPECT technology across various healthcare settings.

View the full single-photon emission computed tomography (spect) market report:
https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Important Industry Leaders Influencing the SPECT Market
Several prominent companies play key roles in shaping the SPECT industry, including:
- GE Healthcare Technologies Inc.
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- United Imaging Healthcare Co. Ltd.
- Mediso Ltd.
- Spectrum Dynamics Medical Inc.
- Digirad Corporation
- Gamma Medica Inc.
- Neusoft Medical Systems Co. Ltd.
- Trasis S.A.
- Curium Pharma
- Lantheus Holdings Inc.
- Bracco Imaging S.p.A.
- Guerbet S.A.
- Eckert & Ziegler AG
- Nordion Inc.
- Bayer AG
- Advanced Accelerator Applications
- Ion Beam Applications S.A.
- Hitachi Ltd.

Strategic Moves Highlighting Market Growth for SPECT
In April 2025, GE Healthcare Technologies, Inc., a leading US diagnostics firm, finalized the acquisition of the remaining 50% ownership stake in Nihon Medi-Physics Co., Ltd. from Sumitomo Chemical, with financial details undisclosed. This move enabled GE Healthcare to gain full control of a major Japanese radiopharmaceutical company, aiming to scale its molecular imaging business, enhance therapeutic diagnostic offerings, and strengthen its position in the expanding nuclear medicine market. Nihon Medi-Physics specializes in the development and production of proprietary and licensed radiopharmaceuticals for SPECT and PET molecular imaging applications.

Emerging Trends and Innovations Shaping the SPECT Market
Leading companies in the SPECT field are focusing on innovation to boost market revenue, particularly through the development of portable gamma cameras. These compact, mobile nuclear imaging devices detect gamma radiation emitted from radiopharmaceuticals within the body, offering flexibility and efficiency in diagnostic procedures.

For example, in June 2023, Serac Imaging, a UK-based molecular imaging specialist, introduced a portable high-resolution hybrid gamma optical camera. This new technology complements existing nuclear medicine equipment, aiming to simplify clinical workflows and increase imaging capacity within healthcare departments.

Overview of Key Segments in the Single-Photon Emission Computed Tomography (SPECT) Market
The SPECT market is categorized across several important segments:

1) By Type:
- Hybrid SPECT Systems
- Standalone SPECT Systems

2) By Radioisotope Type:
- Tc-99m
- Ra-223
- Ga-67
- I-123
- Other Radioisotopes

3) By Application:
- Oncology
- Cardiology
- Neurology
- Other Applications

4) By End User:
- Hospitals
- Diagnostic Centers
- Other End Users

Further subcategories include:
- Hybrid SPECT Systems: SPECT-CT Systems and SPECT-MRI Systems
- Standalone SPECT Systems: Single-Head SPECT Systems and Multi-Head SPECT Systems

This comprehensive segmentation provides a detailed perspective on the diverse offerings and applications within the SPECT market, supporting better understanding of its growth dynamics and future potential.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.